News

We welcome the news that the Bill & Melinda Gates Foundation has awarded Pfizer a $100 million grant to support the development of their Group B Strep vaccine. “Prevention is always better than cure, and a safe and effective group B Strep vaccine will be the best prevention possible to Read more…

The IMPRINT network recently produced the animation resource below explaining Group B Strep vaccines aimed at a general audience. They will also be translating the video into other languages available in 2023. For more IMPRINT GBS videos please visit https://www.imprint-network.co.uk/videos.

On the 5th of October, we joined organisations and individuals around the globe to mark World Meningitis Day 2022. Together, meningitis and neonatal sepsis are the second biggest infectious cause of death in children under five. They can kill in hours, have life-long implications for those that do survive, and have Read more…

The infections that GBS most commonly causes in newborn babies are sepsis (infection of the blood), pneumonia (infection in the lungs) and meningitis (infection of the fluid and lining around the brain). Although GBS infection can make babies very unwell, with prompt treatment, most babies will recover fully. On the Read more…

The Group B Strep International Conference (ISSAD) is looking to form a ‘Young ISSAD’ committee to advise on communication and events leading up to and contributing to ISSAD 2023 in Rio De Janeiro, Brazil. ‘Young ISSAD’ committee meetings will be held via zoom roughly on 4 times a term basis, Read more…

To kickstart GBS Awareness month off I would like to welcome the Group B Strep Support Group of South Africa! This is a support group started by a team of passionate health care professionals with the hopes of improving the awareness and improving treatment of all those affected directly or Read more…

Bronner Gonçalves, Epidemiologist, London School of Hygiene and Tropical Medicine, has released a new article on the ‘Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden’, in Lancet Global Health April 2022. “Better ways to prevent Group B Streptococcus infection are urgently needed to save Read more…

Proma Paul, Research Fellow, London School of Hygiene and Tropical Medicine, has released a new manuscript on the ‘Neurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina’, in Lancet eClinical Medicine 2022. Data are Read more…

“Every Country, Every Family: Group B Streptococcal Disease Worldwide” is a series of nine papers coordinated by LSHTM, funded by the Bill & Melinda Gates Foundation and involving 61 authors from 6 continents. Please find access to the supplement here: https://academic.oup.com/cid/issue/74/Supplement_1?login=false The supplement in Clinical Infectious Diseases presents long term Read more…